"Riociguat for the Treatment of Pulmonary Arterial Hypertension"
NEJM Jul 25
http://www.nejm.org/doi/full/10.1056/NEJMoa1209655
"Riociguat significantly improved exercise capacity and secondary efficacy end points in patients with pulmonary arterial hypertension. (Funded by Bayer HealthCare; . . . "
No comments:
Post a Comment